VAS
ROIV icon

Vestmark Advisory Solutions’s Roivant Sciences ROIV Stock Holding History

Vestmark Advisory Solutions’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Sell
7,249
-12,463
-63% -$368K ﹤0.01% 1326
2026
Q1 		$546K Buy
+19,712
New +$506K 0.01% 1038

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vestmark Advisory Solutions's ROIV Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Roivant Sciences (ROIV) stake by 63% in Q2 2026, selling an estimated $368K and leaving 7,249 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Vestmark Advisory Solutions first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $546K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vestmark Advisory Solutions held 7,249 shares of Roivant Sciences worth $257K as of Q2 2026.
  • Vestmark Advisory Solutions sold 12,463 Roivant Sciences shares in Q2 2026, an estimated $368K.
  • Roivant Sciences made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1326 holding.
  • Vestmark Advisory Solutions first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vestmark Advisory Solutions's Roivant Sciences position peaked at $546K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.